Vivo Capital, LLC Merus N.V. Transaction History

Vivo Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$14.25 - $20.5 $1.21 Million - $1.74 Million	-84,990 Reduced 19.38%	353,600 $6.51 Million
Q4 2022 Feb 13, 2023	SELL	$12.8 - $23.66 $43,648 - $80,680	-3,410 Reduced 0.77%	438,590 $6.79 Million
Q2 2021 Aug 16, 2021	BUY	$20.0 - $25.48 $5.34 Million - $6.8 Million	267,000 Added 152.57%	442,000 $9.31 Million
Q1 2021 May 17, 2021	BUY	$16.14 - $29.11 $2.82 Million - $5.09 Million	175,000 New	175,000 $3.66 Million

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.28B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.